Survival analysis of adjuvant endocrine therapy in HER2 positive early breast cancer patients with low ER positivity. Yu HH, Gracia D, Chao TC, Ho CH, et al. Breast Cancer Res 2025;27:222.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yu HH, Gracia D, Chao TC, Ho CH, et al. Survival analysis of adjuvant endocrine therapy in HER2 positive early breast cancer patients with low ER positivity. Breast Cancer Res 2025;27:222.
PMID: 41466313